www.standoutstocks.com: Stocks That Stand Out For Oct. 13th, 2009 Are FNXC, OWVI, OPXS, ZVTK, VION

Oct 13, 2009 (M2 PRESSWIRE via COMTEX) -- ZVTK | Quote | Chart | News | PowerRating -- Stocks That Standout For Oct. 13th, 2009 are Fonix Speech, Inc. (OTCBB: FNXC), One World Ventures, Inc. (PINKSHEETS: OWVI), Optex Systems Holdings, Inc. (OTCBB: OPXS), Zevotek, Inc. (Pink Sheets: ZVTK), VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION)

Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354 Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.Standoutstocks.com/" www.Standoutstocks.com __________________________________________________

Fonix Logs Nearly Ten Million e-Dictionary and Cell Phone Units Sold through Asian OEMs

Voice Recognition, Text-to-Speech and Voice Compression Technologies Featured in Casio, Canon, Seiko and Inventec Besta Products

LINDON, Utah, Oct 13, 2009 -- Fonix Speech, Inc., a wholly owned subsidiary of Fonix Corporation (OTC BB: FNXC | Quote | Chart | News | PowerRating) specializing in embedded speech interfaces for mobile devices, handheld electronic products, video game systems and processors, today announced that nearly ten million electronic dictionaries and cell phones equipped with Fonix technology have been sold through Asia's largest OEMs internationally.

The e-dictionaries--handheld electronic dictionaries that enable users to speak a word in their native language and have the text read back to them in English--span well-known brands like Casio, Canon, Inventec Besta, Seiko, Brilliant Systems, Topgrade and more. Fonix implements either text-to-speech, voice recognition, voice compression or a combination of these technologies in the devices, all of which are available in Asian markets like China, Korea, Taiwan and Japan.

By far the longest running and most successful items, Casio e-dictionary devices have logged more than 4.9 million units sold in Japan, Korea and China. The Casio line of e-dictionaries consist of 140 different models and feature Fonix text-to-speech and voice compression technologies.

Additionally, Casio Information Systems develops software for Casio and Hitachi cell phones, which are equipped with Fonix text-to-speech technology. Phones with Fonix software have sold nearly 4.6 million units in Japan through Japan's major mobile carrier, au/ KDDI.

"Sales numbers are expanding and market penetration is impressive, but even more exciting for Fonix is the major success in limited markets and the potential for products like these to expand across the world," said D. Lynn Shepherd, Senior VP Engineering and Product Development for Fonix. "Capturing market success in Asia provides leverage with our OEM partners for additional global expansion. The numbers should serve as a validation for our investors and clients of the effectiveness, quality and numerous applications for Fonix technologies." About Fonix: Fonix Corporation (OTC BB: FNXC), based in Lindon, Utah, currently operates through its wholly owned subsidiaries, Fonix Speech, Inc., and Shanghai Gaozhi Software Systems Limited. Fonix Speech is an innovative speech recognition and text-to-speech technology company providing voice solutions for mobile/wireless devices, interactive video games, toys and appliances, computer telephony systems, the assistive market, and automotive telematics. Fonix Speech also provides developers and manufacturers with cost-effective speech solutions to enhance devices and systems.

Shanghai Gaozhi Software Systems Limited ("GaozhiSoft"), based in Shanghai, China, is a leading provider of OSS (Operation Support System) and related software solutions to Chinese mobile network service providers. Founded in 2003, GaozhiSoft software is integrated and widely used in 2G and fixed line networks. In 2008, GaozhiSoft expanded its strategy to include operations as a value-added service provider in the 3G mobile network in China and throughout the Asia Pacific region.

To learn more about Fonix Corporation, visit www.fonix.com; additional information about Fonix Speech can be found at www.fonixspeech.com or by calling (801) 553-6600 and saying "Sales." Go to www.gaozhisoft.com for more information about G-Soft.

Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually," or "projected." Additionally, statements relating to the Company's market position or strength, implementation of the Company's plans or strategies, and comparisons with other companies in the same or similar industries could contain forward-looking statements. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Fonix Corporation expressly disclaims any obligation or intention to update or revise any forward-looking statement, as a result of developments occurring after the date such statement was first made.

One World Ventures, Inc. Tutamen Subsidiary Looks to Green Energy for Mexico

LAS VEGAS, NV, Oct 13, 2009 -- One World Ventures, Inc. (PINKSHEETS: OWVI | Quote | Chart | News | PowerRating) announced today that its manufacturing subsidiary Tutamen, a provider of sourcing and engineering, is close to closing a major solar intuitive for Mexico. To help meet rural Mexico's critical need for low cost energy, Tutamen will provide cost-effective, solar water heat and power generation capability to individual homes.

"This is an exciting opportunity for One World Ventures, Inc. and for the people of Mexico," said Steve Prior, CEO of One World Ventures, Inc. "By taking advantage of modern solar technology, we are able to promote an environmental commitment by producing clean affordable electricity, reducing the carbon footprint, and working to find solutions for meeting the growing energy demands within Mexico's communities." "This is a huge step forward in focusing Tutamen's manufacturing and engineering strengths in a business with massive demand." Tutamen consulting services provides an opportunity for clients to present their vision, challenges and reasons for researching manufacturing or sourcing in China to enable Tutamen experts the insight to quickly move from conceptual planning to implementation.

About One World Ventures, Inc.

One World Ventures, Inc. is a holding company with management resourced in Asia and the United States that invests in technologies, communities and systems that facilitate trade, finance, communication and travel across international boundaries, cultures and languages.

The Company looks for simple inexpensive alternatives to traditional ways of doing business. The strategic goal in every business is in leveraging assets and opportunities globally, focusing on niche markets and providing cost effective operations. The company's unique holdings will provide revenues predominantly derived from memberships, commissions and transactions.

One World Ventures, Inc. business will provide substantial growth and opportunity in the short term and long term. Despite Global economic downturn, 1World Ventures, Inc. is focused to leverage its diversified and global strategies, expanding all of their divisions and adding key personnel to embark on an aggressive marketing and sales program.

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of One World Ventures, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Optex Systems Receives $1.9 Million Purchase Order From General Dynamics Land Systems

RICHARDSON, Texas, Oct 12, 2009 -- Optex Systems Holdings, Inc. (OTCBB:OPXS), a leading manufacturer of optical sighting systems and assemblies primarily for Department of Defense applications, today announced that General Dynamics Land Systems, a business unit of General Dynamics (NYSE:GD), awarded Optex a $1.9 million purchase order for additional ICWS (Improved Commander's Weapon Station) Periscopes. The ICWS Periscopes are a critical component of the M1A2 Abrams Tank; and additionally, Optex is currently manufacturing other plastic periscopes for General Dynamics Land Systems for the M1A2 Abrams Tank.

Delivery of the ICWS Periscopes is scheduled to begin in January 2011 and continue through February 2013.

Danny Schoening, COO of Optex Systems, commented, "We are pleased to have been awarded this latest purchase order with General Dynamics Land Systems. This is the latest step in our ongoing relationship with General Dynamics Land Systems and demonstrates our ongoing track record of delivery of quality products and great customer service. We are proud to be able to continue to provide technology to support the efforts of our troops around the world." ABOUT OPTEX SYSTEMS Optex, which was founded in 1987, is a Richardson, Texas - based ISO 9001:2008 certified concern, which manufactures optical sighting systems and assemblies, primarily for Department of Defense (DOD) applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles, and have been selected for installation on the Stryker family of vehicles. Optex also manufactures and delivers numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Optex delivers its products both directly to the military services and to prime contractors. For additional information, please visit the Company's website at www.optexsys.com.

Safe Harbor Statement This press release and other written reports and oral statements made from time to time by the Company may contain so-called "forward-looking statements," all of which are subject to risks and uncertainties. You can identify these forward-looking statements by their use of words such as "expects," "plans," "will," "estimates," "forecasts," "projects" and other words of similar meaning. You can identify them by the fact that they do not relate strictly to historical or current facts. These statements are likely to address the Company's growth strategy, financial results and product and development programs. You must carefully consider any such statement and should understand that many factors could cause actual results to differ from the Company's forward-looking statements. These factors include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward-looking statement can be guaranteed and actual future results may vary materially.

The Company does not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in the Company's filings with the SEC, especially on Forms 10-K, 10-Q and 8-K. In various filings the Company has identified important factors that could cause actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.

Zevotek Orders Ionic Bulbs for U.S. Sales

NEW YORK, Oct 12, 2009 -- Zevotek, Inc. (Pink Sheets: ZVTK | Quote | Chart | News | PowerRating) (Frankfurt:T5V1), a designer, developer and worldwide direct marketer and distributor of innovative personal and home care items, announced today that it placed a factory order to start producing Ionic Bulbs for U.S. customers. Zevotek is buying Ionic Bulbs to fill anticipated customer orders designed to come from TV and Internet viewers in homes across the U.S. When Zevotek's Ionic Bulb infomercial is broadcast, viewers can see the vivid demonstration of the bulb's ionizing action and immediately contact Zevotek to buy the Ionic Bulb.

The Ionic Bulb is designed for consumer use by combining the performance features of ionic air cleaning technology with those of a 10,000 hour reduced energy use compact fluorescent light bulb (CFL). According to ENERGY STAR(r), a joint program of the U.S. Environmental Protection Agency and the U.S. Department of Energy, a qualified CFL will save about $30 over its lifetime and pay for itself in about 6 months. It uses 75 percent less energy and lasts about 10 times longer than an incandescent bulb. ENERGY STAR(R) said earlier this year that using less energy helps reduce air pollution and greenhouse gas emissions from power plants.

Commenting on the announcement, Zevotek's CEO, Adam Engel, said, "I believe Zevotek's Ionic Bulb is the right product at the right time. Ionic Bulbs deliver the money saving value that U.S. consumers want while improving indoor air quality and helping consumers go green. The Ionic Bulb order announced today is for the CFL equivalent of a 100 watt bulb equipped with Zevotek's exclusively licensed ionizing technology. We plan to have the Ionic Bulbs on hand and ready to ship to customers once we start airing our new 2-minute TV infomercial later next month. " About the Company: Zevotek, Inc. plans to market and sell a range of innovative personal and home care items. Zevotek has a license to sell an energy saving compact fluorescent light bulb named the Ionic Bulb. The Company plans to market the Ionic Bulb through TV infomercials, catalogs, magazines and major U.S. retail and specialty stores and the Internet. Zevotek's Ionic Bulb infomercial airs on www.asseenontv.com and the Company's www.zevo-tek.com website. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Forward-looking statements in this release with respect to the Zevotek, Inc.'s business, financial condition and results of operations, as well as matters of timing and effectiveness of marketing the Ionic Bulb are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond Zevotek, Inc.'s control with respect to market acceptance of their products, whether financing will be available, the plans for Zevotek, Inc. to market and sell products as well as certain other risk factors which are and may be detailed from time to time in Zevotek, Inc.'s filings with the Securities and Exchange Commission.

This press release contains forward-looking statements. The words or phrases 'may,' 'intends,' 'expects,' 'estimate,' 'indicate,' 'plans,' 'anticipates,' 'could,' 'if,' 'will,' 'should' or similar expressions are intended to identify 'forward-looking statements.' Actual results could differ materially from those projected in forward-looking statements as a result of a number of risks and uncertainties. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Zevotek, Inc. cautions readers not to place undue reliance on such statements. Unless otherwise required by applicable law, Zevotek, Inc. does not undertake, and Zevotek, Inc. specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives

NEW HAVEN, Conn., Oct 12, 2009 -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION | Quote | Chart | News | PowerRating) announced today that it had hired the investment banking firm Merriman Curhan Ford & Co. to assist in evaluating its strategic alternatives. These alternatives include any combination of a restructuring of the Company and its debt and a sale of the Company or its assets. The Company may also consider financing options.

As previously reported, the Oncologic Drugs Advisory Committee (ODAC), which is the cancer drug advisory panel of the U.S. Food and Drug Administration (FDA), voted in favor of Vion completing a randomized study defining the efficacy and safety of the Company's lead oncology therapeutic Onrigin(TM) (laromustine) Injection prior to receiving regulatory approval from the FDA. Vion had presented data for Onrigin(TM) for remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML). As Vion would need to raise additional capital to finance a new randomized trial, the Company is evaluating its strategic alternatives. If Vion is unsuccessful in achieving a restructuring, sale, financing or any other strategic transaction or combination thereof, it may have to consider curtailing or ceasing operations or liquidating its assets.

About Vion Pharmaceuticals Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative oncology therapeutics. Vion has two agents in clinical trials, Onrigin(TM) (laromustine) Injection and Triapine(R). The Company has submitted a New Drug Application to the FDA for Onrigin(TM) for remission induction treatment for patients sixty years of age or older with de novo poor-risk AML. The FDA's Oncologic Drug Advisory Committee has recommended to the FDA that a new randomized trial for Onrigin(TM) be completed prior to regulatory approval. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion being unsuccessful in achieving its strategic alternatives, including any combination of a restructuring of the Company and its debt, a sale of the Company or its assets, and raising new capital, in which case it may have to consider curtailing or ceasing operations or liquidating its assets, Vion's potential inability to obtain regulatory approval for its products, particularly Onrigin(TM) (laromustine) Injection, delays in the regulatory approval process, particularly for Onrigin(TM) (laromustine) Injection, delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not confirmed by safety and efficacy results in later or final clinical trials, the need for additional research and testing, including the need for a new randomized trial of Onrigin(TM) prior to regulatory approval in accordance with the recommendation of the Oncologic Drug Advisory Committee, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Form 10-K for the year ended December 31, 2008 and Vion's Form 10-Q for the quarter ended June 30, 2009. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

About Standoutstocks.com www.Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

www.Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at http://www.Standoutstocks.com and select the "join now" button.

Join us at http://www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: http://www.standoutstocks.com/disclaimer.aspx

CONTACT: Jason Hilton, Standout Stocks Tel: +1 585 729 8809 e-mail: Jason@Newmediaadvisorsllc.com e-mail: mailto:info@standoutstocks WWW: http://www.standoutstocks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index